Literature DB >> 28357651

Cancer patients' control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer center.

Markus Schuler1,2, Jan Schildmann3, Freya Trautmann4,5, Leopold Hentschel6, Beate Hornemann6, Anke Rentsch6, Gerhard Ehninger1,6, Jochen Schmitt7,8,6.   

Abstract

PURPOSE: "Shared decision making" has been proposed as a prerequisite of patient-centered care. However, little is known on factors, which may influence cancer patients' decision control preferences (DCP) in routine care. This study investigated possible determinants of the patients' DCP with respect to patient characteristics and patient-reported outcomes (PROs).
METHODS: Consecutive patients presenting at a comprehensive cancer center between May 2014 and October 2014 were offered a self-administered electronic questionnaire including standardized PRO measures and patients' DCP. Results were linked with patient characteristics from the hospital information system and analyzed using cross-sectional methods.
RESULTS: Out of 126 patients participating, 102 (81%; 65% male; mean age 62 years) completed the DCP-item. Overall, 49% (n = 50) preferred shared treatment decision responsibility, 29% (n = 30) preferred to leave the control to his/her physician, whereas 22% (n = 22) preferred to be in control of his/her treatment decision. Higher age (p = 0.035) and elevated distress levels (p = 0.038) were significantly associated with an increased willingness to leave the decision control to the physician. Further sociodemographic and PRO measures were not associated with patients' DCP.
CONCLUSION: Our findings demonstrate that DCP assessment in routine cancer care is possible and provides important information to the treating oncologist. Information on DCP combined with PRO may contribute to more individualized decision making in cancer care.

Entities:  

Keywords:  Decision control preference; Electronic assessment; Oncology; Patient care; Patient-reported outcomes; Routine care

Mesh:

Year:  2017        PMID: 28357651     DOI: 10.1007/s00520-017-3686-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  32 in total

Review 1.  Framework for teaching and learning informed shared decision making.

Authors:  A Towle; W Godolphin
Journal:  BMJ       Date:  1999-09-18

2.  Doctor-patient interactions in oncology.

Authors:  S Ford; L Fallowfield; S Lewis
Journal:  Soc Sci Med       Date:  1996-06       Impact factor: 4.634

3.  Implementation of a mobile inpatient quality of life (QoL) assessment for oncology nursing.

Authors:  Markus K Schuler; Freya Trautmann; Mirko Radloff; Roman Schmädig; Leopold Hentschel; Maria Eberlein-Gonska; Thomas Petzold; Heike Vetter; Sebastian Oberlack; Gerhard Ehninger; Jochen Schmitt
Journal:  Support Care Cancer       Date:  2016-03-16       Impact factor: 3.603

4.  Shared decision-making in primary care: the neglected second half of the consultation.

Authors:  G Elwyn; A Edwards; P Kinnersley
Journal:  Br J Gen Pract       Date:  1999-06       Impact factor: 5.386

5.  The dynamics of change: cancer patients' preferences for information, involvement and support.

Authors:  P N Butow; M Maclean; S M Dunn; M H Tattersall; M J Boyer
Journal:  Ann Oncol       Date:  1997-09       Impact factor: 32.976

6.  Older adults newly diagnosed with symptomatic myeloma and treatment decision making.

Authors:  Joseph D Tariman; Ardith Doorenbos; Karen G Schepp; Seema Singhal; Donna L Berry
Journal:  Oncol Nurs Forum       Date:  2014-07-01       Impact factor: 2.172

Review 7.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

8.  Electronic real-time assessment of patient-reported outcomes in routine care-first findings and experiences from the implementation in a comprehensive cancer center.

Authors:  Freya Trautmann; Leopold Hentschel; Beate Hornemann; Anke Rentsch; Michael Baumann; Gerhard Ehninger; Jochen Schmitt; Markus Schuler
Journal:  Support Care Cancer       Date:  2016-02-18       Impact factor: 3.603

9.  Shared decision making in dermato-oncology: preference for involvement of melanoma patients.

Authors:  Karoline J Albrecht; Dorothée Nashan; Frank Meiss; Jürgen Bengel; Katrin Reuter
Journal:  Melanoma Res       Date:  2014-02       Impact factor: 3.599

10.  Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients.

Authors:  Linda Brom; H Roeline W Pasman; Guy A M Widdershoven; Maurice J D L van der Vorst; Jaap C Reijneveld; Tjeerd J Postma; Bregje D Onwuteaka-Philipsen
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

View more
  4 in total

1.  Impact, challenges and limits of inpatient palliative care consultations - perspectives of requesting and conducting physicians.

Authors:  Anja Coym; Karin Oechsle; Alena Kanitz; Nora Puls; David Blum; Carsten Bokemeyer; Anneke Ullrich
Journal:  BMC Health Serv Res       Date:  2020-02-04       Impact factor: 2.655

2.  Shared decision making and patients satisfaction with strabismus care-a pilot study.

Authors:  Ala Paduca; Oleg Arnaut; Eugeniu Beschieru; Per Olof Lundmark; Jan Richard Bruenech
Journal:  BMC Med Inform Decis Mak       Date:  2021-03-26       Impact factor: 2.796

3.  Psychometric properties of the Shared Decision-Making Questionnaire (SDM-Q-9) in oncology practice.

Authors:  Caterina Calderon; Paula Jiménez-Fonseca; Pere Joan Ferrando; Carlos Jara; Urbano Lorenzo-Seva; Carmen Beato; Teresa García-García; Beatriz Castelo; Avinash Ramchandani; María Mar Muñoz; Eva Martínez de Castro; Ismael Ghanem; Montse Mangas; Alberto Carmona-Bayonas
Journal:  Int J Clin Health Psychol       Date:  2018-02-13

4.  Adaptation and qualitative evaluation of encounter decision aids in breast cancer care.

Authors:  Pola Hahlweg; Isabell Witzel; Volkmar Müller; Glyn Elwyn; Marie-Anne Durand; Isabelle Scholl
Journal:  Arch Gynecol Obstet       Date:  2019-01-16       Impact factor: 2.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.